▶ 調査レポート

世界のドライアイ症候群治療市場

• 英文タイトル:Global Market Study on Dry Eye Syndrome Treatment: Launch of Innovative Treatment Products Complementing Market Growth

Persistence Market Researchが調査・発行した産業分析レポートです。世界のドライアイ症候群治療市場 / Global Market Study on Dry Eye Syndrome Treatment: Launch of Innovative Treatment Products Complementing Market Growth / MRC2105A035資料のイメージです。• レポートコード:MRC2105A035
• 出版社/出版日:Persistence Market Research / 2021年3月
• レポート形態:英文、PDF、314ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥534,100 (USD4,900)▷ お問い合わせ
  Site Licence¥828,400 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,155,400 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートは、世界のドライアイ症候群治療市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、需要分析/予測、価格分析、製品種類別(シクロスポリン、局所コルチコステロイド、人工涙液、涙点プラグ、オメガサプリメント、その他)分析、処方別(Rx、OTC、医療機器)分析、流通チャンネル別(病院薬局、アイヘルスクリニック、小売薬局、オンライン薬局)分析、地域別分析、市場構成分析、競争分析、仮定、調査手法などを掲載しています。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・市場背景
・新型コロナウイルス感染症の危機分析
・需要分析/予測
・価格分析
・世界のドライアイ症候群治療市場規模:製品種類別(シクロスポリン、局所コルチコステロイド、人工涙液、涙点プラグ、オメガサプリメント、その他)
・世界のドライアイ症候群治療市場規模:処方別(Rx、OTC、医療機器)
・世界のドライアイ症候群治療市場規模:流通チャンネル別(病院薬局、アイヘルスクリニック、小売薬局、オンライン薬局)
・世界のドライアイ症候群治療市場規模:地域別
・市場構成分析
・競争分析
・仮定
・調査手法

Dry Eye Syndrome Treatment Market – Scope of Report

A latest publication by Persistence Market Research on the global dry eye syndrome treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The report offers a detailed study of the market background, which includes macroeconomic factors, forecast factors, drivers, restraints, trends, and opportunities in the market. The principal aim of the study is to present exclusive information about how the market will perform over the forecast period of 2020-2030.

Important indicators for successful growth in the dry eye syndrome treatment market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for dry eye syndrome treatment and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the market, including market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the dry eye syndrome treatment market. Insights and wisdom presented in this study can be leveraged by shareholders, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the dry eye syndrome treatment market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, under the data submitted in this market report, minor companies and new entrants in the dry eye syndrome treatment industry can be aided in making suitable company choices to achieve traction in market.

Key Market Segments
Persistence Market Research’s study on the dry eye syndrome treatment market offers information divided into four important segments— product, prescription, distribution channel, and region. This report offers comprehensive data and information about important market dynamics and growth parameters associated with these categories.

Product
Cyclosporine
Topical Corticosteroids
Artificial Tears
Punctal Plugs
Removable
Dissolvable
Omega Supplements
Others

Prescription
Rx
OTC
Medical Device

Distribution Channel
Hospital Pharmacies
Eye Health Clinics
Retail Pharmacies
Online Pharmacies

Region
North America
Latin America
Europe
South Asia

Key Questions Answered in Report
Which regions will continue to remain the most profitable regional markets for dry eye syndrome treatment?
Which factors will induce a change in the demand for dry eye syndrome treatment during the assessment period?
How will changing trends impact the market?
How can market players capture the low-hanging opportunities in developed regions?
What are the winning strategies of stakeholders in the dry eye syndrome treatment market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends in ophthalmic sectors that will impact the market?
How can businesses avail the growth opportunities in developed and emerging sectors?

Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the dry eye syndrome treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the dry eye syndrome treatment market, and makes Persistence Market Research’s projections on the growth prospects of the market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Method Innovation / Development Trends

4. Key Success Factors

4.1. Dry Eye Syndrome Epidemiology, By Country, 2015-2030

4.1.1. Prevalence of dry eye disease

4.1.2. Potential patient number of dry eye disease

4.1.3. Percentage of severity, mild, modulate, and severe

4.1.4. Patients number under treatment

4.1.5. Prevalence of MGD and occurrence rate of dry eye among MGD patient

4.2. Regulatory Scenario

4.3. New Product Launches

4.4. Reimbursement Scenario

4.5. Dry Eye Syndrome- Diagnostics protocol/ Criteria by key countries

4.6. Dry Eye Syndrome – Patient Treatment Journey

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Healthcare Industry Outlook

5.2. Forecast Factors – Relevance & Impact

5.2.1. Increase in Geriatric Population

5.2.2. Increasing Prevalence of Dry Eye Syndrome

5.2.3. Limited Awareness About Dry Eye Syndrome

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Trends

5.3.4. Opportunity Analysis

6. COVID19 Crisis Analysis

6.1. Current COVID19 Statistics and Probable Future Impact

6.2. Current GDP Projection and Probable Impact

6.3. COVID19 and Impact Analysis

6.3.1. Revenue By Product Type

6.3.2. Revenue By Distribution Channel

6.3.3. By Prescription Type

6.3.4. Revenue By Country

7. Global Dry Eye Syndrome Market Demand (In Volume Units) Analysis 2015–2019 and Forecast, 2020–2030

7.1. Historical Market (Volume) Analysis, 2015–2019

7.2. Current and Future Market (Volume) Projections, 2020–2030

7.2.1. Y-o-Y Growth Trend Analysis

8. Global Dry Eye Syndrome Market- Pricing Analysis

8.1. Regional Pricing Analysis By Product

9. Global Dry Eye Syndrome Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020–2030

9.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

9.2. Current and Future Market Value (US$ Mn) Projections, 2020–2030

9.2.1. Y-o-Y Growth Trend Analysis

9.2.2. Absolute $ Opportunity Analysis

10. Global Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030, By Product Type

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) By Product Type, 2015-2019

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020–2030

10.3.1. Cyclosporin

10.3.2. Topical Corticosteroids

10.3.3. Artificial Tears

10.3.4. Punctal plugs

10.3.4.1. Removable

10.3.4.2. Dissolvable

10.3.5. Omega Supplements

10.3.6. Others

10.4. Others Market Attractiveness Analysis By Product Type

11. Global Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030, By Prescription Type

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) By Prescription Type, 2015-2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Prescription Type, 2020–2030

11.3.1. Rx

11.3.2. OTC

11.3.3. Medical Device

11.4. Others Market Attractiveness Analysis By Prescription Type

12. Global Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Mn) By Distribution Channel, 2015-2019

12.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Distribution Channel, 2020–2030

12.3.1. Hospital Pharmacies

12.3.2. Eye Health Clinics

12.3.3. Retail Pharmacies

12.3.4. Online Pharmacies

12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030, by Region

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 – 2019

13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 – 2030

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. East Asia

13.3.5. South Asia

13.3.6. Oceania

13.3.7. Middle East and Africa (MEA)

13.4. Market Attractiveness Analysis By Region

14. North America Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2020–2030

14.3.1. By Country

14.3.1.1. U.S.

14.3.1.2. Canada

14.3.2. By Product Type

14.3.3. By Prescription Type

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.5. Drivers and Restraints – Impact Analysis

15. Latin America Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 – 2019

15.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2020–2030

15.3.1. By Country

15.3.1.1. Brazil

15.3.1.2. Mexico

15.3.1.3. Rest of Latin America

15.3.2. By Product Type

15.3.3. By Prescription Type

15.3.4. By Distribution Channel

15.4. Market Attractiveness Analysis

15.5. Drivers and Restraints – Impact Analysis

16. Europe Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

16.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy 2020–2030

16.3.1. By Country

16.3.1.1. Germany

16.3.1.2. Italy

16.3.1.3. France

16.3.1.4. U.K.

16.3.1.5. Spain

16.3.1.6. Russia

16.3.1.7. Poland

16.3.1.8. Rest of Europe

16.3.2. By Product Type

16.3.3. By Prescription Type

16.3.4. By Distribution Channel

16.4. Market Attractiveness Analysis

16.5. Drivers and Restraints – Impact Analysis

17. South Asia Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy2020–2030

17.3.1. By Country

17.3.1.1. India

17.3.1.2. Thailand

17.3.1.3. Indonesia

17.3.1.4. Malaysia

17.3.1.5. Vietnam

17.3.1.6. Rest of South Asia

17.3.2. By Product Type

17.3.3. By Prescription Type

17.3.4. By Distribution Channel

17.4. Market Attractiveness Analysis

17.5. Drivers and Restraints – Impact Analysis

18. East Asia Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020–2030

18.3.1. By Country

18.3.1.1. China

18.3.1.2. Japan

18.3.1.3. South Korea

18.3.2. By Product Type

18.3.3. By Prescription Type

18.3.4. By Distribution Channel

18.4. Market Attractiveness Analysis

18.5. Drivers and Restraints – Impact Analysis

19. Oceania Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030

19.1. Introduction

19.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2015-2019

19.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020–2030

19.3.1. By Country

19.3.1.1. Australia

19.3.1.2. New Zealand

19.3.2. By Product Type

19.3.3. By Prescription Type

19.3.4. By Distribution Channel

19.4. Market Attractiveness Analysis

19.5. Drivers and Restraints – Impact Analysis

20. Middle East and Africa Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030

20.1. Introduction

20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

20.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020–2030

20.3.1. By Country

20.3.1.1. GCC Countries

20.3.1.2. South Africa

20.3.1.3. North Africa

20.3.1.4. Rest of Middle East and Africa

20.3.2. By Product Type

20.3.3. By Prescription Type

20.3.4. By Distribution Channel

20.4. Market Attractiveness Analysis

20.5. Drivers and Restraints – Impact Analysis

21. Key Countries Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020–2030

21.1. U.S. Dry Eye Syndrome Market Analysis

21.1.1. By Product Type

21.1.2. By Prescription Type

21.1.3. By Distribution Channel

21.2. Canada Dry Eye Syndrome Market Analysis

21.2.1. By Product Type

21.2.2. By Prescription Type

21.2.3. By Distribution Channel

21.3. Brazil Dry Eye Syndrome Market Analysis

21.3.1. By Product Type

21.3.2. By Prescription Type

21.3.3. By Distribution Channel

21.4. Mexico Dry Eye Syndrome Market Analysis

21.4.1. By Product Type

21.4.2. By Prescription Type

21.4.3. By Distribution Channel

21.5. U.K. Dry Eye Syndrome Market Analysis

21.5.1. By Product Type

21.5.2. By Prescription Type

21.5.3. By Distribution Channel

21.6. Germany Dry Eye Syndrome Market Analysis

21.6.1. By Product Type

21.6.2. By Prescription Type

21.6.3. By Distribution Channel

21.7. France Dry Eye Syndrome Market Analysis

21.7.1. By Product Type

21.7.2. By Prescription Type

21.7.3. By Distribution Channel

21.8. Italy Dry Eye Syndrome Market Analysis

21.8.1. By Product Type

21.8.2. By Prescription Type

21.8.3. By Distribution Channel

21.9. Spain Dry Eye Syndrome Market Analysis

21.9.1. By Product Type

21.9.2. By Prescription Type

21.9.3. By Distribution Channel

21.10. Russia Dry Eye Syndrome Market Analysis

21.10.1. By Product Type

21.10.2. By Prescription Type

21.10.3. By Distribution Channel

21.11. Poland Dry Eye Syndrome Market Analysis

21.11.1. By Product Type

21.11.2. By Prescription Type

21.11.3. By Distribution Channel

21.12. Japan Dry Eye Syndrome Market Analysis

21.12.1. By Product Type

21.12.2. By Prescription Type

21.12.3. By Distribution Channel

21.13. China Dry Eye Syndrome Market Analysis

21.13.1. By Product Type

21.13.2. By Prescription Type

21.13.3. By Distribution Channel

21.14. South Korea Dry Eye Syndrome Market Analysis

21.14.1. By Product Type

21.14.2. By Prescription Type

21.14.3. By Distribution Channel

21.15. India Dry Eye Syndrome Market Analysis

21.15.1. By Product Type

21.15.2. By Prescription Type

21.15.3. By Distribution Channel

21.16. Thailand Dry Eye Syndrome Market Analysis

21.16.1. By Product Type

21.16.2. By Prescription Type

21.16.3. By Distribution Channel

21.17. Indonesia Dry Eye Syndrome Market Analysis

21.17.1. By Product Type

21.17.2. By Prescription Type

21.17.3. By Distribution Channel

21.18. Malaysia Dry Eye Syndrome Market Analysis

21.18.1. By Product Type

21.18.2. By Prescription Type

21.18.3. By Distribution Channel

21.19. Vietnam Dry Eye Syndrome Market Analysis

21.19.1. By Product Type

21.19.2. By Prescription Type

21.19.3. By Distribution Channel

21.20. Australia Dry Eye Syndrome Market Analysis

21.20.1. By Product Type

21.20.2. By Prescription Type

21.20.3. By Distribution Channel

21.21. New Zealand Dry Eye Syndrome Market Analysis

21.21.1. By Product Type

21.21.2. By Prescription Type

21.21.3. By Distribution Channel

21.22. GCC Countries Dry Eye Syndrome Market Analysis

21.22.1. By Product Type

21.22.2. By Prescription Type

21.22.3. By Distribution Channel

21.23. South Africa Dry Eye Syndrome Market Analysis

21.23.1. By Product Type

21.23.2. By Prescription Type

21.23.3. By Distribution Channel

22. Market Structure Analysis

22.1. Market Analysis by Tier of Companies

22.2. Market Concentration

23. Competition Analysis

23.1. Competition Dashboard

23.2. Competition Deep Dive

23.2.1. Allergan Plc.

23.2.1.1. Product Portfolio

23.2.1.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.1.3. Sales Footprint

23.2.1.4. Strategy Overview

23.2.1.4.1. Marketing Strategy

23.2.1.4.2. Product Strategy

23.2.1.4.3. Channel Strategy

23.2.2. Novartis AG

23.2.2.1. Product Portfolio

23.2.2.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.2.3. Sales Footprint

23.2.2.4. Strategy Overview

23.2.2.4.1. Marketing Strategy

23.2.2.4.2. Product Strategy

23.2.2.4.3. Channel Strategy

23.2.3. Otsuka Pharmaceutical Co.,Ltd.

23.2.3.1. Product Portfolio

23.2.3.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.3.3. Sales Footprint

23.2.3.4. Strategy Overview

23.2.3.4.1. Marketing Strategy

23.2.3.4.2. Product Strategy

23.2.3.4.3. Channel Strategy

23.2.4. Santen Pharmaceutical Co Ltd.

23.2.4.1. Product Portfolio

23.2.4.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.4.3. Sales Footprint

23.2.4.4. Strategy Overview

23.2.4.4.1. Marketing Strategy

23.2.4.4.2. Product Strategy

23.2.4.4.3. Channel Strategy

23.2.5. Bausch Health Companies Inc.

23.2.5.1. Product Portfolio

23.2.5.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.5.3. Sales Footprint

23.2.5.4. Strategy Overview

23.2.5.4.1. Marketing Strategy

23.2.5.4.2. Product Strategy

23.2.5.4.3. Channel Strategy

23.2.6. Akorn, Inc.

23.2.6.1. Product Portfolio

23.2.6.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.6.3. Sales Footprint

23.2.6.4. Strategy Overview

23.2.6.4.1. Marketing Strategy

23.2.6.4.2. Product Strategy

23.2.6.4.3. Channel Strategy

23.2.7. Johnson & Johnson, Inc.

23.2.7.1. Product Portfolio

23.2.7.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.7.3. Sales Footprint

23.2.7.4. Strategy Overview

23.2.7.4.1. Marketing Strategy

23.2.7.4.2. Product Strategy

23.2.7.4.3. Channel Strategy

23.2.8. Thea Pharmaceuticals Limited

23.2.8.1. Product Portfolio

23.2.8.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.8.3. Sales Footprint

23.2.8.4. Strategy Overview

23.2.8.4.1. Marketing Strategy

23.2.8.4.2. Product Strategy

23.2.8.4.3. Channel Strategy

23.2.9. OASIS Medical

23.2.9.1. Product Portfolio

23.2.9.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.9.3. Sales Footprint

23.2.9.4. Strategy Overview

23.2.9.4.1. Marketing Strategy

23.2.9.4.2. Product Strategy

23.2.9.4.3. Channel Strategy

23.2.10. Altaire Pharmaceuticals Inc.

23.2.10.1. Product Portfolio

23.2.10.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.10.3. Sales Footprint

23.2.10.4. Strategy Overview

23.2.10.4.1. Marketing Strategy

23.2.10.4.2. Product Strategy

23.2.10.4.3. Channel Strategy

23.2.11. Boiron USA

23.2.11.1. Product Portfolio

23.2.11.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.11.3. Sales Footprint

23.2.11.4. Strategy Overview

23.2.11.4.1. Marketing Strategy

23.2.11.4.2. Product Strategy

23.2.11.4.3. Channel Strategy

23.2.12. Similasan Corporation

23.2.12.1. Product Portfolio

23.2.12.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.12.3. Sales Footprint

23.2.12.4. Strategy Overview

23.2.12.4.1. Marketing Strategy

23.2.12.4.2. Product Strategy

23.2.12.4.3. Channel Strategy

23.2.13. Scope Ophthalmics Ltd.

23.2.13.1. Product Portfolio

23.2.13.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.13.3. Sales Footprint

23.2.13.4. Strategy Overview

23.2.13.4.1. Marketing Strategy

23.2.13.4.2. Product Strategy

23.2.13.4.3. Channel Strategy

23.2.14. Reckitt Benckiser Group PLC

23.2.14.1. Product Portfolio

23.2.14.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.14.3. Sales Footprint

23.2.14.4. Strategy Overview

23.2.14.4.1. Marketing Strategy

23.2.14.4.2. Product Strategy

23.2.14.4.3. Channel Strategy

23.2.15. Medicom Healthcare Ltd

23.2.15.1. Product Portfolio

23.2.15.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.15.3. Sales Footprint

23.2.15.4. Strategy Overview

23.2.15.4.1. Marketing Strategy

23.2.15.4.2. Product Strategy

23.2.15.4.3. Channel Strategy

23.2.16. FDC Limited.

23.2.16.1. Product Portfolio

23.2.16.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.16.3. Sales Footprint

23.2.16.4. Strategy Overview

23.2.16.4.1. Marketing Strategy

23.2.16.4.2. Product Strategy

23.2.16.4.3. Channel Strategy

23.2.17. Lupin Limited

23.2.17.1. Product Portfolio

23.2.17.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.17.3. Sales Footprint

23.2.17.4. Strategy Overview

23.2.17.4.1. Marketing Strategy

23.2.17.4.2. Product Strategy

23.2.17.4.3. Channel Strategy

23.2.18. Jamjoom Pharmaceuticals Co.

23.2.18.1. Product Portfolio

23.2.18.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.18.3. Sales Footprint

23.2.18.4. Strategy Overview

23.2.18.4.1. Marketing Strategy

23.2.18.4.2. Product Strategy

23.2.18.4.3. Channel Strategy

23.2.19. Sentiss Pharma Private limited

23.2.19.1. Product Portfolio

23.2.19.2. Profitability by Market Segments (Drugs/Channel/Region)

23.2.19.3. Sales Footprint

23.2.19.4. Strategy Overview

23.2.19.4.1. Marketing Strategy

23.2.19.4.2. Product Strategy

23.2.19.4.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Table 01: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 02: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 03: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 04: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region

Table 05: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 06: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 07: North America Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 08: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 09: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 10: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 11: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 12: Latin America Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 13: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 14: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 15: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 16: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 17: Europe Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 18: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 19: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 20: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 21: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 22: South Asia Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 23: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 24: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 25: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 26: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 27: East Asia Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 28: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 29: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 30: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 31: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 32: Oceania Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 33: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 34: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 35: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 36: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 37: MEA Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 38: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 39: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel